ADMA Biologics Raises 2026 Guidance, Projects Strong Long-Term Growth to $1.1B Revenue by 2029

summarizeSummary

ADMA Biologics announced preliminary unaudited full year 2025 revenue meeting guidance, and significantly raised its financial outlook for 2026 and beyond, projecting over $1.1 billion in annual revenue by 2029.

check_boxKey Events

• Raised 2026 Financial Guidance

  The company increased its expected total revenue for fiscal year 2026 to approximately $635 million (up from $630 million) and Adjusted EBITDA to approximately $360 million (up from $355 million).

• Strong Long-Term Growth Targets

  ADMA introduced new fiscal year 2027 guidance, projecting approximately $775 million in total revenue and $455 million in Adjusted EBITDA. It also targets over $1.1 billion in annual revenue and $700 million in Adjusted EBITDA by fiscal year 2029.

• Strategic Operational Enhancements

  ADMA successfully implemented yield-enhanced production, with 2026 expected to be the first full year of monetizing this. The company also repositioned its plasma collection network, divesting three centers for $12 million and securing long-term plasma supply agreements to enhance margins and supply visibility.

• Solid 2025 Performance

  Preliminary unaudited full year 2025 total revenue is estimated at $510-$511 million, meeting or exceeding prior guidance. The company ended 2025 with approximately $88 million in cash, including $40 million in operating cash flow generated in Q4 2025.

auto_awesomeAnalysis

ADMA Biologics delivered a comprehensive positive update, significantly raising its financial outlook for 2026 and providing robust long-term targets through 2029. The increased revenue and Adjusted EBITDA guidance for 2026, coupled with new, strong projections for 2027 and a target of over $1.1 billion in annual revenue by 2029, signals accelerating growth and expanding profitability. Strategic operational improvements, such as the successful implementation of yield-enhanced production and the repositioning of its plasma network, are expected to drive margin expansion and ensure long-term supply. These factors collectively indicate strong business momentum and management's confidence in future performance.